摘要
目的:分析抗甲状腺药物治疗妊娠合并甲状腺功能亢进对胎儿的影响。方法:以2015年1月~2018年12月某院接收的58例妊娠合并甲状腺功能亢进患者为观察对象,随机分为对照组和研究组,对照组为非抗甲状腺药物治疗的患者,研究组为接受抗甲状腺药物治疗的患者,对比两组效果。结果:研究组妊娠合并甲状腺功能亢进患者FT3、FT4及TSH水平较对照组优,研究组妊娠合并甲状腺功能亢进患者并发症发生概率为3.45%,比对照组低17.24%,研究组新生儿Apgar评分较对照组高,组间对比有统计意义(P<0.05)。结论:抗甲状腺药物治疗妊娠合并甲状腺功能亢进效果明显,且对胎儿生长发育无不良影响。
Objective:To analyze the effect of antithyroid drugs on fetus in pregnant women with hyperthyroidism.Methods:58 patients with pregnancy complicated with hyperthyroidism treated in a hospital from January 2015 to December 2018 were selected and randomly divided into control group and study group.The control group was treated with non-antithyroid,and the study group treated with antithyroid drugs,then the results of two groups were compared.Results:The levels of FT3,FT4 and TSH in the study group were better than those in the control group.The incidence of complications in the study group was 3.45%,which was lower than that in the control group(17.24%).The neonatal Apgar score in the study group was higher than that in the control group(P<0.05).Conclusion:The effect of antithyroid drugs in the treatment of hyperthyroidism in pregnancy is obvious and has no adverse effect on fetal growth and development.
作者
李锦雯
Li Jinwen(Huaxian Traditional Chinese Medicine Hospital,Anyang,Henan Province,Anyang 456400)
出处
《数理医药学杂志》
2020年第8期1186-1187,共2页
Journal of Mathematical Medicine
